Pharmacokinetics for the Pharmaceutical Scientist

  title={Pharmacokinetics for the Pharmaceutical Scientist},
  author={John G. Wagner},
  • J. Wagner
  • Published 20 April 1993
  • Biology, Chemistry, Medicine
Simple Linear Models More Complicated Linear Models Complicated Linear Models Linear Multicompartment Disposition Parameters from Extravascular Downslope C,T Data Noncompartmental and System Analysis Linear Multiple Dose Equations Simple Nonlinear Models More Complicated Nonlinear Models Urinary Excretion Absorption Analysis and Bioavailability Physiological Pharmacokinetics Relationship between Physiologically Based Flow Models and Usual Compartment Models Protein Binding Pharmacokinetic… 
A single compartment simulation model of pharmacokinetics
For better understanding about derivation of various parameters related to pharmacokinetics, this model is developed. Animals or human volunteers are not used in this model but the principles used in
Pharmacokinetic modeling in toxicology : a critical perspective 1
The present contribution reviews the most basic pharmacokinetic models, their development, and their applications in toxicology.
A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.
Application of the valid equation may result in much faster initial drop of drug plasma concentration time curve and significantly longer terminal half-life, especially for low extraction ratio drugs.
Optimal Design for Multiresponse Pharmacokinetic–Pharmacodynamic Models – Dealing with Unbalanced Designs
This paper proposes an optimal design method to take into account the unbalanced nature of the problem and applied it to a PKPD problem that involved describing the time course of drug plasma concentrations, heart rate and mean arterial blood pressure for both a fixed effects and mixed effects regression model.
Statistical model and inference for pharmacokinetic data
In this paper, we consider a statistical model for the drug concentration–time profiles that are obtained in a pharmacokinetic (PK) study when the drug is orally administered. In the proposed